Literature DB >> 18764882

Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.

Angel Díaz-Lagares1, Estibaliz Alegre, Joel LeMaoult, Edgardo D Carosella, Alvaro González.   

Abstract

Human leucocyte antigen G (HLA-G) is a tolerogenic molecule that protects the fetus from maternal immune attack, may favour tumoral immunoescape and is up-regulated in viral and inflammatory diseases. The aim of this work was to discover if nitric oxide (NO) could affect HLA-G expression or function because NO is an important modulator of innate and adaptive immunity. For this purpose HLA-G expression and function were analysed following treatment with a NO donor or a peroxynitrite donor in various cell lines expressing HLA-G either spontaneously or upon transfection. Results showed NO-dependent nitration of both cellular and soluble HLA-G protein, but not all HLA-G moieties underwent nitration. Endogenous biosynthesis of NO by both U-937-HLA-G1 and M8-HLA-G5 stable transfectants also caused HLA-G nitration. The NO decreased total HLA-G cellular protein content and expression on the cell surface, while increasing HLA-G shedding into the culture medium. This effect was post-transcriptional and the result of metalloprotease activity. By contrast, NO pretreatment did not affect HLA-G capability to suppress NK cytotoxicity and lymphocyte proliferation. Our studies show that NO regulates the availability of HLA-G molecules without modifying their biological activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18764882      PMCID: PMC2669824          DOI: 10.1111/j.1365-2567.2008.02911.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.

Authors:  Estibaliz Alegre; Angel Díaz-Lagares; Joel Lemaoult; Natalia López-Moratalla; Edgardo D Carosella; Alvaro González
Journal:  Hum Immunol       Date:  2007-05-25       Impact factor: 2.850

2.  Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide.

Authors:  L Connelly; M Palacios-Callender; C Ameixa; S Moncada; A J Hobbs
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.

Authors:  Utta Berchner-Pfannschmidt; Hatice Yamac; Buena Trinidad; Joachim Fandrey
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

4.  HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.

Authors:  B Riteau; N Rouas-Freiss; C Menier; P Paul; J Dausset; E D Carosella
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  Nitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress.

Authors:  Tobias Jung; Martina Engels; Lars-Oliver Klotz; Klaus-Dietrich Kröncke; Tilman Grune
Journal:  Free Radic Biol Med       Date:  2006-12-02       Impact factor: 7.376

Review 6.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

7.  Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by gamma-glutamyltranspeptidase.

Authors:  R Roozendaal; E Vellenga; M A de Jong; K F Traanberg; D S Postma; J G de Monchy; H F Kauffman
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

8.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells.

Authors:  Joel LeMaoult; Julien Caumartin; Marina Daouya; Benoit Favier; Solene Le Rond; Alvaro Gonzalez; Edgardo D Carosella
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

9.  Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.

Authors:  I Zidi; C Guillard; C Marcou; I Krawice-Radanne; D Sangrouber; N Rouas-Freiss; E D Carosella; P Moreau
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

10.  Quantification and identification of soluble HLA-G isoforms.

Authors:  V Rebmann; J LeMaoult; N Rouas-Freiss; E D Carosella; H Grosse-Wilde
Journal:  Tissue Antigens       Date:  2007-04
View more
  10 in total

Review 1.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

3.  Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.

Authors:  E Favoino; I E Favia; S Vettori; C Vicenti; M Prete; G Valentini; F Perosa
Journal:  Clin Exp Immunol       Date:  2015-05-10       Impact factor: 4.330

Review 4.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

Review 5.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

Review 6.  HLA-G: a human pregnancy-related immunomodulator.

Authors:  Joan S Hunt; Daudi L Langat
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

7.  Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

Authors:  Roberta Rizzo; Alessandro Trentini; Daria Bortolotti; Maria C Manfrinato; Antonella Rotola; Massimiliano Castellazzi; Loredana Melchiorri; Dario Di Luca; Franco Dallocchio; Enrico Fainardi; Tiziana Bellini
Journal:  Mol Cell Biochem       Date:  2013-06-05       Impact factor: 3.396

Review 8.  Immunological deregulation in classic hodgkin lymphoma.

Authors:  Alessandra Romano; Calogero Vetro; Giovanni Caocci; Marianna Greco; Nunziatina Laura Parrinello; Francesco Di Raimondo; Giorgio La Nasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

Review 9.  The dual role of HLA-G in cancer.

Authors:  Nathalie Rouas-Freiss; Philippe Moreau; Joel LeMaoult; Edgardo D Carosella
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

Review 10.  Some basic aspects of HLA-G biology.

Authors:  Estibaliz Alegre; Roberta Rizzo; Daria Bortolotti; Sara Fernandez-Landázuri; Enrico Fainardi; Alvaro González
Journal:  J Immunol Res       Date:  2014-04-09       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.